SCHEMBL14059977

SCHEMBL14059977

CN(C)C(=O)c1cccc(-c2ccc3c(NCCC4CC4)c(C(N)=O)nnc3c2)c1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 20/20 0.54
▸ PDGFRA P16234 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059515 0.92 LRRK2 (0.58) LRRK2PDGFRA
SCHEMBL14059953 0.86 LRRK2 (0.62) LRRK2PDGFRA
SCHEMBL14059530 0.85 LRRK2 (0.70) LRRK2PDGFRA
SCHEMBL14059470 0.85 FYN (0.42) LRRK2
SCHEMBL14059118 0.85 LRRK2 (0.71) LRRK2
SCHEMBL14059806 0.83 LRRK2 (0.69) LRRK2PDGFRA
SCHEMBL14059623 0.81 LRRK2 (0.58) LRRK2PDGFRA
SCHEMBL17135880 0.81 LRRK2 (0.76) LRRK2PDGFRA
SCHEMBL17135879 0.81 LRRK2 (0.76) LRRK2PDGFRA
SCHEMBL14059531 0.81 LRRK2 (0.75) LRRK2PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP claimed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO claimed
Send feedback